Additionally, this study reveals that the recurrence rates of GPP within 52 weeks, from highest to lowest, are: IL-36 inhibitors (21% [95% CI 9%-28%]), TNF-alpha inhibitors (20% [95% CI 2%-46%]), IL-17 inhibitors (15% [95% CI 1%-37%]), and IL-23 inhibitors (5% [95% CI 0%-29%]). The gene discussed is TNF; the disease is psoriasis 14, pustular.